Summary The relationship between body mass index (BMI, Quetelet's index, kg m-2) and post-menopausal breast cancer risk was considered in age-specific strata on the basis of a pooled analysis of three Italian case-control studies, including a total of 3108 postmenopausal breast cancer patients aged 50 years or over and 2664 control subjects. Overall, there was a moderate, but significant, association between BMI and post-menopausal breast cancer: the odds ratios (ORs) were around 1.3 for the three intermediate quintiles compared with the lowest one, and 1.4 for the highest one. The association was moderate among women aged 50-59 years and 60-69 years, with ORs around 1.3 for the highest BMI quintiles, but stronger among elderly women, with ORs of 1.6 for the fourth and 2.1 for the fifth quintile. An 8-unit increase in BMI involved an OR of 1.18 at age 50-59 years, of 1.14 at age 60-69 years and of 1.59 above age 70 years. This pattern of risk is similar to that observed for post-menopausal hormone replacement treatment and is consistent with a duration-risk relationship in the exposure to high oestrogen levels and with a greater differential in oestrogen levels in overweight elderly women. In terms of population attributable risk, 19.6% of all post-menopausal breast cancer patients and 27.1% of those in women above age 70 years were attributable to overweight and obesity in this population. This has, therefore, major preventive implications as to reduce breast cancer risk late in life, it is essentially important to control weight gain in elderly women.
Being overweight and obese have been consistently associated with increased breast cancer risk in post-menopausal women. This is attributed to elevated levels or availability of circulating oestrogens in obese post-menopausal women due to the conversion of androgens to oestrogens in peripheral adipose tissue and to lower levels of sex hormone-binding globulin (SHBG) in overweight women (Pike et al, 1983; Hunter and Willett, 1993; Stoll, 1994) .
A direct trend in risk has been observed between postmenopausal breast cancer and measures of body mass index (BMI) (Pike et al, 1983; Hsieh et al, 1990; Hunter and Willett, 1993; Stoll, 1994) , but little attention has been paid to measures of the duration-risk relationship or to any other time factor. It is conceivable, in fact, that the association increases with prolonged exposure to overweight-related high oestrogen levels, i.e. with longer intervals after menopause. Furthermore, several studies on exogenous oestrogens (hormonal replacement treatment, HRT) and breast cancer have tended to show stronger associations with advancing age (Colditz et al, 1995; For example the American Nurses' Health Study (Colditz et al, 1995) found a relative risk of 1.4 for long term (2 5 years) current users of HRT below age 55 years, but of 1.7 at age 60-64 years. This may also reflect a gradual increase in the difference of oestrogen levels In a cooperative case-control study of 2566 cases and 2588 controls conducted in various Italian regions (Franceschi et al, 1996) , the relative risk for the highest vs the lowest BMI quintile was 1.1 at age 50-59 years, 1.5 at age 60-69 years and 2.9 at age 70 years and over. This would suggest that the strength of the association between BMI and breast cancer risk increases with advancing age.
Given the relevance of this issue for individual risk assessment and to the public health, we considered the age-specific pattern of the relationship between BMI and breast cancer risk in postmenopausal women, using pooled data from three other Italian case-control studies.
MATERIALS AND METHODS
The design and methods of the original investigations and their pooled analysis have been described in detail (Negri et al, 1988a) . Briefly, the first study (Toti et al, 1986 ) was a cooperative hospitalbased case-control investigation conducted between 1980 and 1983 in 13 breast cancer clinics from ten Italian provinces (eight from northern Italy, one from central and one from southern Italy). A total of 1556 incident, histologically confirmed cases were interviewed, together with 1473 controls admitted for acute, orthopaedic, medical or surgical conditions unrelated to risk factors for breast cancer and to long-term modification of diet (such as peptic ulcer and other gastric disorders, Crohn's disease or ulcerative colitis, diabetes mellitus, hyperuricaemia or any other metabolic condition). The second study (Talamini et al, 1985) was based on 373 breast cancer cases recruited between 1980 and 1983 at the General Hospital of Pordenone, north eastern Italy. Cases were matched for age (± 5 years) with 368 controls recruited in the same region and admitted to the same hospital for acute, non-neoplastic and non-hormone-related conditions that were unrelated to nutrition or diet.
The third study (Tavani et al, 1993 ) was a hospital-based case-control investigation conducted between 1983 and 1991 in the Greater Milan area on a total of 3425 histologically confirmed breast cancer cases below age 75 years who were admitted to a network including the major teaching and general hospitals in the area. The comparison group included 2926 women admitted to the same network of hospitals for acute conditions (35% traumas, 13% other orthopaedic disorders, 22% surgical, 30% other miscellaneous disorders) that were also unrelated to long-term modification of diet and similar to cases in terms of age and area of residence.
Data analysis
We obtained a single file including similar items of information from the three studies. Odds ratios (ORs) of breast cancer, and the corresponding 95% confidence intervals (CI), with reference to BMI (Quetelet's index, kg m-2) were obtained using unconditional multiple logistic regression, fitted by the method of maximum likelihood (Breslow and Day, 1980) , including terms for (1) study centre and quinquennia of age and (2) age at menarche, parity and age at first birth, age at menopause plus age and study centre. As the results from the two models were similar, only the latter are presented. BMI was introduced into the model also as a continuous variable and set at 8-unit increase, i.e. the difference between a woman at normal weight and one who is morbidly obese (Ursin et al, 1995) .
RESULTS
Post-menopausal women aged 50 years or over were considered, totalling 3108 cases and 2664 controls. Their distribution according to age and study is given in Table 1  Table 2 gives the OR of post-menopausal breast cancer in quintiles of BMI for the overall dataset by age group. Overall, there was a moderate, but significant, association between BMI and post-menopausal breast cancer. Compared with thin women (BMI <21.8 kg m-2), the OR was already above unity for those with BMI between 21.8 and 23.8 and further increased in obese women. The ORs were around 1.3 for the three intermediate quintiles compared with the lowest one, and 1.4 for the highest quintile. The association was moderate among women aged 50-59 years and 60-69 years, with ORs around 1.3 for the two highest BMI quintiles, but stronger in elderly women, with ORs of 1.6 for the fourth and 2.1 for fifth quintile. The interaction with age was significant (P<0.01). aEstimates from multiple logistic regression models including terms for study centre, age, age at menarche, parity and age at first birth, and age at menopause. bReference category. NS, not significant.
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An 8-unit increase in BMI involved an OR of 1.18 at age 50-59 years, of 1.14 at age 60-69 years, and of 1.59 at over age 70 years (overall OR, 1.23).
In this study, there was no relationship between height and breast cancer risk in post-menopausal women: the OR for the highest quintile (.166 cm) compared with the lowest one (<156 cm) was 1.0 (95% CI 0.8-1.1).
DISCUSSION
The present study not only confirms that overweight and obese women are at increased risk of post-menopausal breast cancer (Pike et al, 1983; Hsieh et al, 1990; Hunter and Willett, 1993; Stoll, 1994) , but also indicates that such an association becomes stronger with advancing age.
A few studies have considered lifetime weight change and have generally found that weight gains were related to breast cancer risk (Ballard-Barbash et al, 1990; Brinton and Swanson, 1992; BarnesJosiah et al, 1995) . It is unclear, however, to what extent the role of weight gain was explained by a positive correlation with BMI at diagnosis. Little attention has been paid to a possible modifying effect of age on the association between BMI and post-menopausal breast cancer. A case-control study from Israel (Lubin et al, 1985) showed a larger difference in BMI for elderly (2 60 years) breast cancer patients than for post-menopausal ones below age 60 years compared with both hospital and population controls. Another Italian case-control study (Franceschi et al, 1996) showed that the association between BMI and breast cancer risk tended to increase with the passing of time after menopause.
As measures of height and weight were self-reported in this study it is possible that inaccuracy in recall influenced the results. In particular, a non-differential misclassification should have reduced the association observed, however it is unlikely that any such bias has caused such an interaction with age as to determine the patterns of risk observed. The results were similar in the three studies considered, across major diagnostic categories of controls (traumas and other orthopaedic, acute surgical, other miscellaneous) and not materially influenced by allowance for a number of covariates. As all the studies considered were hospital-based, and as it is conceivable that the BMI of the controls may fall with advancing age, this may have led to some overestimation of the OR. On the other hand, as obesity is associated with a broad spectrum of chronic conditions (Negri et al, 1988b) , it is conceivable that the ORs are somewhat understimated using hospital controls. However, the comparison groups specifically excluded chronic diseases or any condition likely to be related to changes in diet, and hence, in body weight.
The pattern of risk observed in this dataset is consistent with a duration-risk relationship (Day, 1983) between being overweight and post-menopausal breast cancer, and with a role for being overweight and obesity at one of the latter stages of the process of carcinogenesis (Peto, 1977; Day and Brown, 1980) . This also has important implications for prevention as the incidence of breast cancer increases with age (Pike et al, 1983; Pike, 1987) . Consequently, the absolute breast cancer excess risk related to being overweight is even larger at elderly age than indicated by the relative risk estimates. To reduce breast cancer risk, therefore, it seems important to avoid obesity at elderly age, and weight loss, even late in life, may still be important.
This age-related pattern of risk is also similar to that observed for hormone replacement treatment in post-menopausal women among whom the relative risk increases with advancing age (Colditz et al, 1995; . Besides confirming the similarities, for hormone-dependent carcinogenesis, of exogenous and endogenous oestrogens (Henderson, 1985) , this may also reflect an increasing differential in oestrogen levels between women of normal weight and overweight with advancing age. There is, therefore, convincing biological support to the epidemiological observation of a stronger association between BMI and breast cancer risk with advancing age.
In terms of population attributable risk (Bruzzi et al, 1985; Mezzetti et al, 1996) , on the theoretical assumption that all women could be shifted to the lowest BMI level, 19.6% of all postmenopausal breast cancer cases and 27.1% of those above age 70 years in this population were attributable to being overweight and obese. This has relevant implications on an individual risk assessment and on a public health scale for weight control in elderly women.
